Status
Conditions
Treatments
About
The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.
Full description
The trial was designed as a real-world observational study to recruit those patients with pathologically diagnosed early-phase non-small cell lung cancer (NSCLC) who were enrolled in the clinical form 2009 to 2017 and explore recurrence/metastases of the NSCLC patients as measured by patient survivals and the impact factors of patient survivals. The study data on patient demographic characteristics, tumor biological characteristics, and clinicla treatments were collected via a retrospectively review method for evaluation of patient survivals and the relevance of clinical characteristics of the patients and patient survivals.
Enrollment
Sex
Volunteers
Inclusion criteria
The patients who meet all the following inclusion criteria will be included in the study:
Exclusion criteria
Loading...
Central trial contact
Jianxing HE, MD; Wenhua LIANG, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal